Locations:
SearchAdvertisement
Modification of traditional staging factors associated with survival in high-risk disease
Hyperthermia, neoadjuvant chemoradiation and reconstruction hold promise of long-term survival
Dose and neutrophil-to-lymphocyte ratio are key factors
Recruitment open for Phase III trial of immunotherapy plus chemotherapy and radiotherapy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Radiation planning technique safely reduces toxicity
Truly personalized radiotherapy may be within reach
Minimizing patient discomfort, improving quality of life
Innovative treatments control cancer recurrence
Largest retrospective study to date confirms randomized trials
A study of patients with brain metastases treated with SRS
Advertisement
Advertisement